Product Information

TADALAFIL 20 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.1582 per EA under NDC 24979073044. Its NADAC has been published 75 times since Mar 19, 2025.

FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TADALAFIL 20 MG TABLET

Tadalafil
$0.1582per EA

Strength

20 mg/1

NDC

24979073044

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA210420

FDA Approved

3/26/2019

TE Code

AB1

On Market Since

4/7/2024

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for TADALAFIL 20 MG TABLET has been published 75 times since Mar 19, 2025, and over the history we have for it it has declined 31.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1582 per EA
All-time high$0.2307 (May 14, 2025)
All-time low$0.1582 (Aug 19, 2026)
52-week high$0.2171
52-week low$0.1582
Median price$0.2085
Average price$0.2031
Largest weekly change-5.7% (Jan 21, 2026)
Weeks tracked75
Tracking sinceMar 19, 2025

Price History

1W

-2.7%

1M

-2.7%

3M

-11.9%

6M

-17.7%

1Y

-27.2%

3Y

N/A

5Y

N/A

All

-31.2%

Generic Alternatives

The matcher finds 18 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TADALAFIL 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 20 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1582 per EA (NDC 24979073044), effective Aug 19, 2026.

How has the price of TADALAFIL 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for TADALAFIL 20 MG TABLET has declined 31.2%. It has been tracked across 75 weekly CMS publications since Mar 19, 2025.

What are the highest and lowest recorded NADAC prices for TADALAFIL 20 MG TABLET?

Since Mar 19, 2025, the NADAC for TADALAFIL 20 MG TABLET has ranged from a low of $0.1582 (Aug 19, 2026) to a high of $0.2307 (May 14, 2025), with a median of $0.2085 per EA.

Are there cheaper alternatives to TADALAFIL 20 MG TABLET?

Yes. 18 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALYQ 20 MG TABLET, is $0.1400 per EA — about 11% below TADALAFIL 20 MG TABLET.

Who manufactures TADALAFIL 20 MG TABLET?

TADALAFIL 20 MG TABLET (NDC 24979073044) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.